One-Year Follow-Up of Clinical and Morphological Outcomes in Elite Athletes With Early-Stage Lower Extremity Tendinopathy

Little is known about early tendinopathy in elite athletes. This study aimed to investigate changes in clinical and ultrasonography outcomes over 1 year and assess the prognostic values of these outcomes at baseline with respect to tendinopathy progression. Sixty-two elite athletes (24 +/- 5 years) with early phase (symptom duration < three months) Achilles or patellar tendinopathy (AT and PT) were examined at baseline and after one year. Pain-guided activity modification was the only intervention. Clinical outcomes were assessed using Victorian Institute of Sports Assessment questionnaires (VISA) for function and symptoms, pain scores (1-10 numerical rating scale (NRS)) and ultrasound tendon morphology (thickness, echogenicity and power Doppler (PD) flow area). A linear mixed-effects model analysed changes from baseline to 1 year. Athletes showed clinical improvements in VISA-Achilles (baseline: 66 +/- 5 vs. one-year: 87 +/- 2, 95% CI: 13-30, p < 0.0001 and effect size d = 3.8), VISA-Patella (baseline: 69 +/- 3 vs. one-year: 86 +/- 1, 95% CI: 10-26, p < 0.0001 and effect size d = 3.6) scores and most NRS pain scores (>= 2 points). Tendinopathic Achilles tendons' peritendinous thickness was reduced (-0.79 mm, p = 0.0188 and effect size d = 0.5), whereas patellar tendons remained enlarged. For both AT and PT, lower baseline PD was associated with a greater reduction in thickness over time (p < 0.001) and higher baseline VISA scores were linked to greater increases in echo intensity over time (p = 0.0363). In conclusion, elite athletes with early phase AT and PT showed clinical improvement over 1 year, with morphological changes in tendinopathic Achilles tendons only. Lower baseline PD and better initial VISA scores represent a better prognosis for tendinopathy morphology and symptoms.